Thông tin cho nhân viên y tế
Thuốc mới và thông tin từ Drugs.com
- CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) approved Tonmya™ (cyclobenzaprine…
- GERMANTOWN, Md, Aug. 15, 2025 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced that the US Food and Drug…
- Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for…
- BRIDGEWATER, N.J., Aug. 12, 2025 /PRNewswire/ — Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases…
- TORONTO, ON – August 11, 2025 – PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of…
- Ridgefield, Conn., U.S. and Ingelheim, Germany , August 8, 2025 — Boehringer Ingelheim’s Hernexeos (zongertinib tablets) has been approved by the U.S. Food and Drug Administration (FDA). The kinase inhibitor is indicated for the treatment of…
- WEDNESDAY, Aug. 20, 2025 — Adults with hearing loss (HL) with hearing aids have a reduced risk for dementia, according to a research letter published online Aug. 18 in JAMA Neurology. Lily Francis, M.B.B.S., from the University of Texas Health…
- WEDNESDAY, Aug. 20, 2025 — From 2013 to 2018, older adults with heart failure, stroke, and hypertension experienced significant declines in Life's Essential 8 (LE8) scores, according to a study published online Aug. 20 in the Journal of the…
- WEDNESDAY, Aug. 20, 2025 — Novel subcutaneous electroencephalography (sqEEG) systems, consisting of a small electrode placed beneath the skin, are feasible and acceptable for monitoring seizures in the long term, according to a study published…
- WEDNESDAY, Aug. 20, 2025 — Boarding is a considerable issue for Medicaid-enrolled youths seeking mental health care in emergency departments (EDs), according to a research letter published online Aug. 15 in JAMA Health Forum. K. John McConnell…
- WEDNESDAY, Aug. 20, 2025 — Benevolent childhood experiences (BCEs) have a protective effect against disordered eating behaviors, according to a study published online Aug. 6 in Adversity and Resilience Science. Cynthia Y. Yoon, from Pusan National…
- WEDNESDAY, Aug. 20, 2025 — In adults with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, the anti-interleukin 4Rα monoclonal antibody stapokibart improves outcomes, according to a study published…
Thông tin từ The Pharma Letter
- Japanese ophthalmology major Santen Pharmaceutical has licensed the Asia rights to Chinese biopharma RemeGen’s VEGF/FGF-targeted eye drug RC28-E, a PIII therapy for wet age-related macular degeneration (wAMD), in a deal worth up to 1.3 billion renminbi ($181 million).
- Elix has announced that fellow Japanese firm Kyorin Pharmaceutical has adopted Elix Discovery, its proprietary AI-powered drug discovery platform.
- The US Food and Drug Administration (FDA) has lifted the clinical hold on Rocket Pharmaceuticals’ pivotal Phase II trial of RP-A501 for the treatment of Danon disease, the company revealed today, sending its shares up a robust 22% to $3.56 in early trading.
- Swiss pharma company Idorsia announced that its novel dual endothelin receptor antagonist (ERA), Tryvio (aprocitentan), has been included in the new comprehensive clinical practice guidelines for the management of systemic hypertension, published by the American College of Cardiology (ACC) and the American Heart Association (AHA) Joint Committee.
- VantAI, a specialist in generative AI for proximity drug discovery, and Halda Therapeutics, a company focused on regulated induced proximity targeting chimeras (RIPTAC), have agreed a strategic research collaboration worth more than $1 billion in total potential value, inclusive of upfront and milestone payments across multiple targets.
- AlzeCure Pharma, a Swedish pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, has appointed Cecilia Wadell as head of development.
Thông tin từ BioPharmaDive
- A deal to acquire Alkermes spinout Mural Oncology is Xoma’s fourth since June and the latest evidence of interest in buying and shutting down struggling drugmakers.
- Anne White, a 30-year company veteran who previously led the company’s oncology unit, will step down as head of Lilly Neuroscience at the end of December.
- The company plans to continue with a lower dose and a change in the pre-treatment regimen after a trial participant died earlier this year.
- RFK Jr. has his sights set on increasing oversight and enforcement against drugmakers that run afoul of advertising laws.
- The company’s market value was nearly cut in half following trial results showing higher rates of treatment discontinuations among people receiving Viking’s drug.
- On an earnings call, CSL CEO Paul McKenzie described weakness in the U.S. market for seasonal flu vaccines as “disappointing” and “highly irrational.”
Thông tin từ STAT News
- How AI provider tools will probably drive up health care costs
- Epic’s AI overhaul promises to address EHR headaches for clinicians and patients
- A new heart risk model had raised questions about who should take statins. A new study to "right-size" yields a similar answer to the old model.
- And more biotech news, brought to you by The Readout.
- And other Morning Rounds health news updates.
- Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business
Thông tin từ Nature Review Drug Discovery
- Nature Reviews Drug Discovery, Published online: 14 August 2025; doi:10.1038/d41573-025-00139-2Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development.
- Nature Reviews Drug Discovery, Published online: 12 August 2025; doi:10.1038/d41573-025-00135-6Neutrophil-targeted drug secures first FDA approval for inflammatory lung disease
- Nature Reviews Drug Discovery, Published online: 07 August 2025; doi:10.1038/d41573-025-00137-4Leading orexin receptor agonist clears phase III for narcolepsy
- Nature Reviews Drug Discovery, Published online: 07 August 2025; doi:10.1038/d41573-025-00136-5Small-molecule PI3Kα binder with selective anticancer activity
- Nature Reviews Drug Discovery, Published online: 07 August 2025; doi:10.1038/d41573-025-00138-3FDA grants first US approval for decades-old eye drug
- Nature Reviews Drug Discovery, Published online: 05 August 2025; doi:10.1038/d41573-025-00134-7In vivo engineering broadens CAR-T cell therapy use